Stem Cell Research (Oct 2020)

Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C

  • K.R. Valetdinova,
  • M.A. Maretina,
  • Y.V. Vyatkin,
  • M.P. Perepelkina,
  • A.A. Egorova,
  • V.S. Baranov,
  • A.V. Kiselev,
  • P.M. Gershovich,
  • S.M. Zakian

Journal volume & issue
Vol. 48
p. 101941

Abstract

Read online

Duchenne muscular dystrophy (DMD) is a severe and rapidly progressive hereditary muscular disease with X-linked recessive inheritance, occurring mainly in males. A complete loss of dystrophin resulted from out-of-frame deletion mutations in the DMD gene leads to Duchenne muscular dystrophy. DMD induced pluripotent stem cells (iPSCs) are a suitable cell model to study muscle development and disease mechanisms underlying muscular dystrophy and to screen novel compounds with potential therapeutic effects. We generated iPSCs from a DMD patient using non-integrating episomal plasmid vectors. The obtained iPSC lines showed ESC-like morphology, expression pluripotency markers, displayed a normal karyotype and possessed trilineage differentiation potential.